undamentalytics Newsletter
Sign in

GE HealthCare income statement

In fiscal 2025, GE HealthCare reported revenue of $20.63bn, up 4.8% on the year before, operating income of $2.76bn (a 13.4% margin) and net income of $2.08bn, or $4.55 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue17.618.319.619.720.621.6
Gross profit7.27.27.98.28.28.6
Research and development0.81.01.21.31.31.3
Selling, general and administrative3.63.64.34.34.24.4
Operating income2.82.52.42.62.82.9
Income before tax2.92.52.42.62.82.8
Income tax0.60.60.70.50.60.6
Net income2.21.91.62.02.12.2
Diluted EPS$4.95$4.22$3.03$4.34$4.55$4.73
Diluted shares (average)454m454m458m459m458m456m
EBITDA3.02.82.72.93.13.2

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BSX vs GEHCGEHC vs PHGGEHC vs SYKGEHC vs MDT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from GE HealthCare's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to GE HealthCare.